Sodium Management in Acute Neurological Injury

Sodium Management in Patients With Acute Neurological Injury

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01558843

Acronym

SANI

Enrollment

400

Registered

2012-03-20

Start date

2012-02-01

Completion date

2016-10-01

Last updated

2019-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This Study is to Understand the Current Practice of Sodium Management in Acute Neurological Injury

Keywords

Sodium Management, Neurointensive Care, Hyponatremia

Brief summary

This multicenter, observational, study will enroll severe neurologically injured patients both prospectively and retrospectively. The aims are to identify the percent of neurocritical care patients with sodium levels ≤ 135 mEq/L, describe treatment strategies employed, determine the correlation of clinical factors (i.e. GCS, ICP) with serum sodium concentrations in patients prior to sodium altering therapy, and evaluate outcomes through evaluation of length of stay, discharge disposition, and modified Rankin score (mRS).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age ≥ 18 years of age * admitted to an intensive care unit for more than 48 hours * ICD-9 codes for aneurysmal SAH, TBI, IPH, or intracranial tumor.

Countries

United States

Outcome results